An open clinical study to evaluate the efficacy of trial drug suganthamalli chooranam for lasunathabitham

An open clinical study to evaluate the clinical efficacy of siddha sasthric formulation suganthamalli chooranam for the treatment of lasunathabitham

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/014950

Enrollment

Registered

2018-07-18

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Lasunathabitham Health Condition 2: J030- Streptococcal tonsillitis

Interventions

Intervention1: Suganthamalli chooranam: 2g according to the body weight tds with milk orally for 14 days Control Intervention1: not applicable: not applicable

Eligibility

Inclusion criteria

Inclusion criteria: Patient with appropriate symptoms of throat pain dysphagia hoarseness of voice enlarged tonsils referred pain in the ear malaise mild fever with tonsillitis

Exclusion criteria

Exclusion criteria: congenital anomalies of pharynx physiological hyperplasia of lymphoid follicles malignancy tonsillitis which have indication for surgery tonsilolith quincy

Design outcomes

Primary

Measure	Time frame
The therapeutic efficacy of trial drug SUGANTHAMALLI CHOORANAM on LASUNATHABITHAMTimepoint: 14 days	—

Secondary

Measure	Time frame
Evaluation of siddha diagnostic parametersTimepoint: 14 days	—

Countries

India

Contacts

Public ContactK RUBA

Govt Siddha Medical College Palayamkottai

Shyamsujisathya@gmail.com9442277124

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026